Search results for: 'drug part'
- Related search terms
- drug 01 00 00 00
- part 01 00 00 00
- parts 01 00 00 00
- part solutions in the global hydrogen production market
- parts solutions in the global hydrogen production market
-
17 Jan 2022  |  Global  |  Technology Research
Global Advances in Omics Technologies Enable Future Drug Discovery and Growth Opportunities
Emerging Omics Platforms Drive Precision Drug Discovery
For a long time, drug discovery followed the same path and used conventional analysis methods for proposed targets. Today, changes in technology and the ability to study omics are transforming drug development. Personalized therapy is on the rise and promises to be more effective and efficient in addressing challenges. With growing interest in ...
$4,950.00
Special Price $3,712.50 save 25 %
-
29 Jun 2023  |  Global  |  Technology Research
Synthetic Biology (SynBio) in Drug Discovery and Next-generation Therapeutics
Disruptive Technology Advances in SynBio Foster a Thriving Stakeholder Ecosystem and Accelerate Biopharma Developments
The SynBio field has evolved well over the past two decades, with significant technology disruptions leading to new opportunities and remarkable growth potential. Advances in SynBio technologies have transformed drug discovery and therapeutics development, accelerating the identification of novel drug targets and high-throughput compound screening ...
$4,950.00
Special Price $3,712.50 save 25 %
-
20 Feb 2024  |  North America  |  Market Research
Growth Opportunities in Drug Discovery and Early Development Outsourcing Services
M&As, Partnerships, and the Shift Toward an End-to-end CRDMO Model will Boost Sector Expansion
The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity. Overall R&D expenditure totals about $276....
$4,950.00
Special Price $3,712.50 save 25 %
-
11 Sep 2024  |  Global  |  Market Research
Automotive Aftermarket Parts Distributors and Retailers, North America, 2024
eCommerce and Private Label Brands Are Driving Transformational Growth by Strengthening Competitors Market Positions and Enhancing Their Profitability While Improving the Overall Customer Experience
This study examines major automotive aftermarket parts distributors and retailers in North America (the United States and Canada) between 2019 and 2023. The research highlights the trends, impact of technological evolution, shifting market dynamics, and product and customer engagement. By profiling key distributors and retailers, this study exp...
$4,950.00
Special Price $4,207.50 save 15 %
-
11 Nov 2016  |  North America  |  Market Research
Global Orphan Drug Market
High Pricing and Undefined Reimbursement Policies will Limit the Sales of Orphan Drugs
The treatment of rare diseases requires the use of specialized drugs. Patient populations for rare diseases are most often quite small, consequently the products treating them earn the designation orphan drugs. These drugs must undergo the research, development, and clinical trials that all drugs do, yet the investment into the development is great...
$6,000.00
Special Price $4,500.00 save 25 %
-
29 Nov 2021  |    |  Technology Research
Technology Developments in Synthetic Biology for Drug Discovery and Diagnostics
Advances in DNA, RNA, Protein Printing, and Automation Technologies to Drive Adoption of Synthetic Biology in the Next Three Years
The conventional drug discovery and diagnostics technologies are unable to cope up with the current disease management practices. To this end, researchers have explored possibilities beyond life sciences. Specifically, they have figured out that the use of engineering principles to biological systems can revolutionize the drug discovery and diagnos...
$4,950.00
Special Price $3,712.50 save 25 %
-
29 Dec 2017  |  North America  |  Technology Research
Innovations in Transdermal Drug Delivery
Microneedle Technologies Creating Novel Opportunities in Transdermal Drug Delivery Industry
With the healthcare industry moving toward patient convenience and comfort, pharmaceutical and medical device companies are continuously researching for the most effective, side effect free, convenient route of drug delivery. Transdermal drug delivery is a painless method of delivering drug formulation. Transdermal route of drug administration has ...
$4,950.00
Special Price $3,712.50 save 25 %
-
17 Oct 2025  |  Global  |  Technology Research
Recent Advances in Biologics and AI-based Drug Discovery and Development
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides actionable insights across new developments in prebiotics, immunology, oncology, cell and gene therapies, antibody therapies, and precision medicine approaches. The TOE also encompasses technology advances across the use of AI and ML in drug discovery a...
$950.00 -
16 Jun 2020  |  Global  |  Technology Research
Material Technologies Facilitating Targeted Drug Delivery
Nanomaterials are Gaining Research Focus for Targeted Drug Delivery
Targeted drug delivery is gaining traction owing toward significant demand for improvement in the drug delivery efficiency as well as the need to mitigate potential side-effects, which can occur due to drug accumulation. The concept of targeted drug delivery is not new, the technology started gaining pace with the advent of nanotechnology and bioco...
$4,950.00
Special Price $3,712.50 save 25 %
-
01 Mar 2024  |  North America  |  Market Research
Global Orphan Drug Growth Opportunities
Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions
In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...
$4,950.00
Special Price $3,712.50 save 25 %